A Test of Y90 Glass Beads for Brain Cancer That Came Back
Original title: An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed, and the team is still looking for the right dose.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests tiny glass beads that carry radiation right into a brain tumor.
Who this trial is for. This trial is for people whose brain cancer has come back. It tests very small glass beads, called Y90, that give radiation to the tumor and the area near it.
Where it stands. The trial has not reported results. The study team wants to find the best dose. They are also checking if the beads are safe, and if they help stop the tumor from growing. The answers are not in yet.
What this means, and what it doesn't
What it could mean: Radiation is a normal part of care for most brain cancers. This way of giving it is new and still being tested. The beads go in through a blood vessel in the forearm or groin, using a thin tube. After that there is a hospital stay of up to 36 hours, then regular check-ups with the study doctor. Someone who fits this picture could ask their care team about it.
What it doesn't mean: This does not mean the beads work. A trial is a test, not a proven treatment. Being in a trial is not a promise that you will do better. It is not a cure.
Source: ClinicalTrials.gov, October 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.